Suppliers and packagers for generic pharmaceutical drug: DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE

DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Baxter Hlthcare	DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 10MEQ	dextrose; potassium chloride; sodium chloride	INJECTABLE;INJECTION	018037	NDA	Baxter Healthcare Company	0338-0663-04	1000 mL in 1 BAG (0338-0663-04)	1979-02-02
Baxter Hlthcare	DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 15MEQ (K)	dextrose; potassium chloride; sodium chloride	INJECTABLE;INJECTION	018037	NDA	Baxter Healthcare Company	0338-0663-04	1000 mL in 1 BAG (0338-0663-04)	1979-02-02
Baxter Hlthcare	DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 20MEQ	dextrose; potassium chloride; sodium chloride	INJECTABLE;INJECTION	018037	NDA	Baxter Healthcare Company	0338-0663-04	1000 mL in 1 BAG (0338-0663-04)	1979-02-02

Pharmaceutical Drug Component Sourcing Analysis: Dextrose, Potassium Chloride, Sodium Chloride

Last updated: February 19, 2026

This report analyzes the global supplier landscape for three critical pharmaceutical excipients: dextrose, potassium chloride, and sodium chloride. It identifies key manufacturers, regional distribution, production capacities, and regulatory compliance considerations relevant to pharmaceutical supply chain integrity. The objective is to provide actionable intelligence for procurement and R&D professionals evaluating sourcing strategies for intravenous fluid and electrolyte replacement therapies.

What are the primary pharmaceutical applications for dextrose, potassium chloride, and sodium chloride?

Dextrose, potassium chloride, and sodium chloride are fundamental components in numerous pharmaceutical formulations, primarily for intravenous (IV) solutions.

• Dextrose is a simple sugar, also known as glucose. In pharmaceuticals, it serves as a primary energy source in IV solutions for patients who cannot consume food orally or require nutritional support. Common concentrations range from 5% (D5W) to 10% in water. Dextrose solutions are also used as diluents for other injectable medications.
• Potassium Chloride (KCl) is an electrolyte essential for cellular function, nerve impulse transmission, and muscle contraction. Pharmaceutical preparations of KCl are used to correct hypokalemia (low blood potassium levels). It is frequently formulated in saline solutions (e.g., 0.9% Sodium Chloride Injection) at various concentrations, such as 20 mEq/L or 40 mEq/L, for IV administration.
• Sodium Chloride (NaCl) is a vital electrolyte that maintains fluid balance and blood volume. Pharmaceutical-grade sodium chloride is the active ingredient in normal saline solutions (0.9% NaCl), which are used for IV fluid replacement, to dilute medications, and as a vehicle for administering other electrolytes like potassium. Higher concentrations, such as 3% or 5% sodium chloride, are used for specific therapeutic indications like treating severe hyponatremia or cerebral edema.

Who are the leading global manufacturers of pharmaceutical-grade dextrose?

The production of pharmaceutical-grade dextrose involves stringent quality control and adherence to pharmacopeial standards (e.g., USP, EP, JP). Key global manufacturers include:

• Cargill, Incorporated: A major producer of corn-based sweeteners, including dextrose. They operate significant production facilities in North America and Europe.
• ADM (Archer Daniels Midland Company): Another large agricultural processor with extensive starch and sweetener production capabilities, including pharmaceutical-grade dextrose, primarily from corn. Their facilities are located in North America and South America.
• Ingredion Incorporated: A global ingredients solutions company that produces corn-derived sweeteners, including dextrose monohydrate and anhydrous dextrose, for pharmaceutical and food industries. They have a substantial manufacturing presence in North America and Europe.
• Roquette Frères: A French company specializing in plant-based ingredients, including dextrose derived from wheat and corn. They have production sites in Europe and North America.
• Global Bio-chem Technology Group Company Limited: A Chinese manufacturer of biochemical products, including dextrose monohydrate. Their primary manufacturing base is in China.

These companies typically produce dextrose monohydrate and dextrose anhydrous, with specific grades tailored for pharmaceutical use, ensuring low impurity profiles and consistent physicochemical properties.

What is the production capacity and regional concentration for pharmaceutical-grade potassium chloride?

Pharmaceutical-grade potassium chloride is a refined mineral salt produced from various sources, including mined sylvinite ore and brines. Global production is concentrated in regions with significant mineral reserves and established chemical manufacturing infrastructure.

Key producing regions and significant manufacturers include:

• North America (United States, Canada): Companies like Morton Salt (a K+S AG subsidiary) and Albemarle Corporation are significant suppliers. Production capacity is integrated with other salt and chemical manufacturing operations.
• Europe: K+S AG (Germany) is a major European potash producer, supplying refined KCl for various industrial and pharmaceutical applications. Uralkali (Russia) also has significant global output, though its primary market is fertilizer, with pharmaceutical grades available. ICL Group (Israel) is another substantial global producer from Dead Sea brines, with pharmaceutical-grade material available.
• Asia (China, Russia): China possesses substantial mining and chemical processing capabilities, with numerous domestic producers of industrial and pharmaceutical salts. Russia, through companies like Uralkali, is a global leader in potash production.

Production volumes are substantial, with the majority of global potash production dedicated to fertilizers. However, a dedicated portion of refined output is specifically processed to meet stringent pharmacopeial requirements for purity, particle size, and low heavy metal content, which is essential for IV solutions. Specific pharmaceutical-grade production capacities are not always publicly disclosed but are estimated to be in the hundreds of thousands of metric tons annually to meet global demand.

Which suppliers offer pharmaceutical-grade sodium chloride and their approximate scale?

Pharmaceutical-grade sodium chloride, commonly known as "bacteriostatic water for injection" when preserved, or simply as a purified salt for sterile solutions, is produced globally. The scale of production for pharmaceutical applications is significant, though often a subset of a company's overall salt production.

Major suppliers and their approximate scale considerations:

• Cargill, Incorporated: Offers high-purity, pharmaceutical-grade sodium chloride from various sources, including vacuum evaporated salt and rock salt. They have a substantial presence in North America and Europe. Their scale is large, catering to both food and pharmaceutical industries.
• AkzoNobel N.V. (now Nouryon): While AkzoNobel has divested many specialty chemical businesses, its former salts operations, particularly in Europe, were significant producers of high-purity salts.
• K+S AG: Produces high-purity vacuum salt and rock salt. Their European facilities are a major source for pharmaceutical-grade NaCl.
• US Salt, LLC (a subsidiary of Compass Minerals): A significant producer of evaporated salt in the United States, with grades suitable for pharmaceutical applications.
• China National Salt Industry Corporation: As the state-owned entity, it oversees vast salt production in China, including refined grades for pharmaceutical use. The sheer volume of Chinese salt production makes it a globally significant source.

The scale of production for pharmaceutical-grade sodium chloride is vast, easily in the millions of metric tons annually globally, as it forms the basis of normal saline solutions used universally in healthcare. Suppliers often produce this material through processes like vacuum evaporation or solar evaporation, followed by refining steps to achieve USP/EP purity standards.

What are the key regulatory and quality standards for these pharmaceutical components?

Adherence to stringent regulatory and quality standards is non-negotiable for pharmaceutical excipients. Manufacturers must comply with pharmacopeial monographs and regulatory guidelines in their target markets.

Key standards include:

• United States Pharmacopeia (USP): The USP sets standards for the identity, strength, quality, and purity of medicines. Monographs for Dextrose (various forms), Potassium Chloride, and Sodium Chloride specify tests and acceptance criteria. Manufacturers must demonstrate compliance with USP standards, including limits for heavy metals, related substances, and microbial contamination.
• European Pharmacopoeia (EP): Similar to the USP, the EP sets legally binding standards for medicinal substances in Europe. Compliance with EP monographs is required for products intended for the European market.
• Japanese Pharmacopoeia (JP): The JP sets standards for pharmaceuticals in Japan.
• Good Manufacturing Practices (GMP): Manufacturers must adhere to GMP regulations established by regulatory bodies such as the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and others. GMP ensures that products are consistently produced and controlled according to quality standards. This includes robust quality management systems, validated manufacturing processes, and meticulous documentation.
• ICH Guidelines: The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use provides guidelines on various aspects of pharmaceutical development and manufacturing, including quality (Q series) and impurities.

Suppliers must maintain Certificates of Analysis (CoAs) for each batch, detailing compliance with specified tests. Audits by pharmaceutical companies and regulatory authorities are common to verify GMP compliance and supply chain integrity.

How do supply chain disruptions impact the availability of these essential pharmaceutical ingredients?

The supply chains for dextrose, potassium chloride, and sodium chloride are complex and can be vulnerable to disruptions, impacting the availability of critical IV fluids and electrolyte therapies.

Key factors and impacts:

• Raw Material Sourcing:
  • Dextrose: Dependent on agricultural outputs (corn, wheat). Extreme weather events (droughts, floods) can affect crop yields and subsequently dextrose pricing and availability. Geopolitical issues affecting major agricultural regions can also pose risks.
  • Potassium Chloride: Primarily sourced from mined potash. Labor strikes at mines, geopolitical instability in major producing countries (e.g., Russia, Belarus), or trade disputes can limit supply.
  • Sodium Chloride: Sourced from mining, solar evaporation, or vacuum evaporation. Energy costs (for vacuum evaporation), environmental regulations affecting coastal evaporation sites, or natural disasters impacting salt flats can create localized or broader supply issues.
• Manufacturing and Logistics:
  • Energy Costs: Production of refined salts and dextrose is energy-intensive. Volatile energy prices can affect manufacturing costs and potentially lead to production slowdowns or shutdowns if margins are squeezed.
  • Transportation: Global shipping availability and costs are critical. Port congestion, container shortages, and rising freight rates can delay deliveries and increase landed costs. Dependence on single shipping routes or a limited number of logistics providers increases vulnerability.
  • Labor Shortages: Skilled labor shortages in manufacturing and logistics sectors can impact production capacity and timely distribution.
• Regulatory Changes: Unexpected changes in import/export regulations, new purity requirements, or heightened scrutiny of manufacturing sites can disrupt established supply lines.
• Geopolitical Factors: Trade wars, sanctions, and political instability in key producing or transit regions can lead to sudden supply restrictions or significant price volatility. For instance, reliance on a single country for a specific grade of a component becomes a significant risk.
• Pandemics and Health Crises: As demonstrated by recent global events, pandemics can lead to widespread manufacturing shutdowns, labor absenteeism, and extreme demand spikes for essential medicines and their components, severely straining supply chains.

Consequences of disruptions include: shortages of IV fluids, price escalations for essential medicines, and the need for pharmaceutical companies to expedite the qualification of alternative suppliers, which is a time-consuming and resource-intensive process.

What are the key considerations for qualifying new suppliers of these pharmaceutical ingredients?

Qualifying a new supplier for pharmaceutical-grade dextrose, potassium chloride, or sodium chloride is a rigorous process involving multiple stages to ensure product quality, supply reliability, and regulatory compliance.

Key considerations:

• Regulatory Compliance and Documentation:
  • Pharmacopeial Compliance: The supplier must demonstrate consistent adherence to USP, EP, JP, or other relevant pharmacopeial standards for the specific grade required.
  • GMP Certification: Verification of current Good Manufacturing Practices (GMP) through on-site audits and review of audit reports from recognized regulatory bodies (e.g., FDA, EMA) or third-party auditors.
  • Regulatory Filings: Access to relevant Drug Master Files (DMFs) or equivalent documentation filed with regulatory agencies, facilitating the supplier's inclusion in the pharmaceutical company's drug product filings.
  • Quality Agreements: Establishment of a comprehensive Quality Agreement outlining the responsibilities of both parties regarding quality control, change management, batch release, and complaint handling.
• Technical and Manufacturing Capabilities:
  • Manufacturing Process: Detailed understanding and validation of the supplier's manufacturing process, including raw material sourcing, purification steps, and packaging.
  • Quality Control Systems: Robust in-house analytical testing capabilities, validated test methods, and well-maintained laboratory equipment.
  • Capacity and Scalability: Assessment of current production capacity and the supplier's ability to scale up production to meet demand fluctuations and future growth.
  • Supply Chain Traceability: Ability to trace raw materials through to the finished product, essential for recall management and root cause analysis of any quality issues.
  • Change Control Management: A formal process for managing and communicating any changes to the manufacturing process, raw materials, analytical methods, or packaging that could impact product quality.
• Supply Chain Reliability and Risk Management:
  • Financial Stability: Evaluation of the supplier's financial health to ensure long-term viability.
  • Business Continuity and Disaster Recovery: Review of the supplier's plans for managing disruptions (e.g., natural disasters, equipment failures, labor disputes).
  • Logistics and Distribution Network: Assessment of their global distribution capabilities and reliability to ensure timely and secure delivery.
  • Auditing History and Track Record: Review of past audit findings (regulatory and customer) and their corrective actions.
• Cost and Commercial Terms:
  • Competitive Pricing: Benchmarking against existing suppliers and market rates, while balancing cost with quality and reliability.
  • Contractual Terms: Clear negotiation of supply contracts, including pricing, delivery schedules, payment terms, and liability.

The qualification process typically involves extensive documentation review, site audits, sample testing, and often a trial run or validation batch before full commercial supply is approved.

Key Takeaways

• Pharmaceutical-grade dextrose, potassium chloride, and sodium chloride are primarily supplied by large chemical and agricultural processing companies with global manufacturing footprints.
• Key manufacturers of dextrose include Cargill, ADM, Ingredion, and Roquette, predominantly utilizing corn and wheat as raw materials.
• Potassium chloride supply is dominated by major potash producers like K+S AG, ICL Group, and Uralkali, with production concentrated in regions with significant mineral reserves.
• Sodium chloride, a high-volume commodity with pharmaceutical grades, is produced by diversified salt producers such as Cargill, K+S AG, and Compass Minerals, alongside major Chinese manufacturers.
• Strict adherence to USP, EP, JP, and GMP standards is paramount for all suppliers.
• Supply chain disruptions stemming from agricultural variability, geopolitical instability, energy costs, and logistics challenges pose significant risks to the availability of these essential pharmaceutical ingredients.
• Supplier qualification is a comprehensive process focusing on regulatory compliance, manufacturing robustness, quality control, supply chain reliability, and financial stability.

Frequently Asked Questions

1. What is the typical lead time for qualifying a new supplier for these excipients? The qualification process for a new supplier typically ranges from 6 to 18 months, depending on the complexity of the supplier's operations, the depth of the required audits, and the speed of documentation exchange and validation testing.

2. Are there specific regional dependencies for pharmaceutical-grade ingredients that pose a higher risk? Yes, reliance on a single country or a limited number of countries for mining (potash) or specific refining capabilities can create higher regional dependencies. For example, geopolitical events affecting major potash-producing nations can have a significant impact.

3. How do fluctuations in commodity prices for corn or potash affect the cost of these pharmaceutical ingredients? Significant fluctuations in the commodity prices of corn (for dextrose) or potash (for potassium chloride) directly influence the raw material cost for manufacturers, which can then translate to increased pricing for the pharmaceutical-grade ingredients, especially during periods of scarcity or high demand.

4. What are the primary differences between industrial-grade and pharmaceutical-grade versions of these salts and sugars? Pharmaceutical-grade ingredients undergo significantly more rigorous purification processes to meet stringent pharmacopeial standards. They have lower limits for impurities, heavy metals, microbial contamination, and specific endotoxins, ensuring patient safety. Industrial grades are not subject to these exacting standards.

5. How frequently are suppliers audited by pharmaceutical companies? Routine supplier audits are typically conducted every 1 to 3 years, depending on the risk profile of the supplier and the criticality of the ingredient. However, unscheduled audits can be initiated in response to quality concerns, significant process changes, or major regulatory actions.

Citations

[1] United States Pharmacopeia. (n.d.). USP-NF Online. Retrieved from https://online.uspnf.com/ [2] European Directorate for the Quality of Medicines & HealthCare. (n.d.). European Pharmacopoeia. Retrieved from https://www.edqm.eu/ [3] International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. (n.d.). ICH Guidelines. Retrieved from https://www.ich.org/ [4] Archer Daniels Midland Company. (2023). Annual Report. [5] Cargill, Incorporated. (2023). Company Information. [6] Ingredion Incorporated. (2023). Annual Report. [7] K+S AG. (2023). Annual Report. [8] ICL Group. (2023). Annual Report. [9] Compass Minerals. (2023). Annual Report. [10] Roquette Frères. (2023). Company Information.